Glen Eagle Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.1K | Hold |
110
| – | – | ﹤0.01% | 525 |
|
|
2025
Q1 | $24.6K | Hold |
110
| – | – | ﹤0.01% | 519 |
|
|
2024
Q4 | $36K | Hold |
110
| – | – | 0.01% | 471 |
|
|
2024
Q3 | $33K | Hold |
110
| – | – | 0.01% | 494 |
|
|
2024
Q2 | $36.2K | Hold |
110
| – | – | 0.01% | 458 |
|
|
2024
Q1 | $43.5K | Hold |
110
| – | – | 0.01% | 429 |
|
|
2023
Q4 | $38.7K | Hold |
110
| – | – | 0.01% | 425 |
|
|
2023
Q3 | $41.3K | Hold |
110
| – | – | 0.01% | 405 |
|
|
2023
Q2 | $42.1K | Hold |
110
| – | – | 0.01% | 397 |
|
|
2023
Q1 | $38.1K | Hold |
110
| – | – | 0.01% | 406 |
|
|
2022
Q4 | $25.9K | Hold |
110
| – | – | 0.01% | 458 |
|
|
2022
Q3 | $27.1K | Hold |
110
| – | – | 0.01% | 437 |
|
|
2022
Q2 | $33.3K | Hold |
110
| – | – | 0.01% | 424 |
|
|
2022
Q1 | $45.2K | Hold |
110
| – | – | 0.01% | 386 |
|
|
2021
Q4 | $51.6K | Hold |
110
| – | – | 0.01% | 367 |
|
|
2021
Q3 | $46.7K | Hold |
110
| – | – | 0.01% | 389 |
|
|
2021
Q2 | $39.5K | Hold |
110
| – | – | 0.01% | 421 |
|
|
2021
Q1 | $31K | Hold |
110
| – | – | 0.01% | 432 |
|
|
2020
Q4 | $31.2K | Hold |
110
| – | – | 0.01% | 407 |
|
|
2020
Q3 | $30.2K | Buy |
+110
| New | +$30.2K | 0.01% | 381 |
|
|
2019
Q4 | – | Sell |
-48
| Closed | -$6.81K | – | 932 |
|
|
2019
Q3 | $6.81K | Buy |
+48
| New | +$6.81K | ﹤0.01% | 582 |
|